Effect of glutathione depletion on Ifosfamide nephrotoxicity in rats

• Published in: International journal of biomedical science Vol. 4; no. 3; pp. 171 - 174
• Main Authors: Garimella-Krovi, Sudha, Springate, James E
• Format: Journal Article
• Language: English
• Published: United States Master Publishing Group 01-09-2008
• Subjects: kidney; ifosfamide; toxic nephropathy; buthionine sulfoximine; glutathione
• ISSN: 1550-9702; 1555-2810
• DOI: 10.59566/IJBS.2008.4171

Kidney injury is an important side effect of the chemotherapeutic agent ifosfamide in humans. Previous studies have shown that treatment with ifosfamide reduces kidney glutathione and that the toxicity of ifosfamide is enhanced in glutathione-depleted renal tubule cells in vitro. In this study, we examined the effect of glutathione depletion on ifosfamide nephrotoxicity in vivo using rats treated with the glutathione-depleting agent buthionine sulfoximine. Animals received 80 mg/kg ifosfamide intraperitoneally daily for three days with or without buthionine sulfoximine in drinking water. Buthionine sulfoximine produced a significant fall in renal glutathione content but did not affect kidney function. Ifosfamide-treated rats developed low-grade glucosuria, phosphaturia and proteinuria that worsened with concomitant buthionine sulfoximine therapy. These findings indicate that glutathione depletion exacerbates ifosfamide nephrotoxicity in rats and suggest that pharmacological methods for replenishing intracellular glutathione may be effective in ameliorating ifosfamide-induced renal injury.